NCT05786638View on ClinicalTrials.gov

Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

October 10, 2022

Study Completion Date

March 10, 2023

Conditions
Efficacy, Self
Interventions
DRUG

Allergen Immunotherapy Extract

Sublingual subcutaneous allergen immunotherapy

Trial Locations (1)

35511

Mansoura university Faculty of medicine, Al Mansurah

All Listed Sponsors
lead

Mansoura University Hospital

OTHER

NCT05786638 - Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma | Biotech Hunter | Biotech Hunter